Learn more at Federation of American Scientists (FAS), Emerging Technology, DAY ONE PROJECT

A Quantitative Imaging Infrastructure to Revolutionize AI-Enabled Precision Medicine

Related Articles

CaliberMRI User Group Session 2 – June – The variability of Mean ADC Measurements with Simultaneous Multi-slice Imaging in a NIST/QIBA/CaliberMRI Diffusion Phantom

Join us for Session 2:  Tuesday, June 24th, 9:00 AM (MDT).  To sign up or for login details, please email info[at]qmri.com.
Topic: The variability of Mean ADC Measurements with Simultaneous Multi-slice Imaging in a NIST/QIBA/CaliberMRI Diffusion Phantom
Guest Speakers: Dr. Ryckie Wade, PhD, and Matthew Marzetti, MsC, University of Leeds, United Kingdom

November 18th – User Group Session | Traumatic Brain Injury, the TRACK-TBI Study, Data, and Quantitative Imaging | Dr. Pratik Mukherjee (UCSF)

Topic: Traumatic Brain Injury, the TRACK-TBI Study, Data, and Quantitative Imaging
Guest Speaker:  Dr. Pratik Mukherjee MD, PhD, UCSF

Dr. Mukherjee is a Professor in Residence in the Department Radiology and Biomedical Imaging, Bioengineering, and he is an attending neuroradiologist at the University of California, San Francisco. He is the Director of the Center for Imaging of Neurodegenerative Disease (CIND) based at the San Francisco VA Medical Center. He also directs the Neural Connectivity Laboratory (NCL) at UCSF China Basin.

 Dr. Mukherjee’s primary clinical research is the study of neurodevelopmental disorders and traumatic brain injury (TBI) using advanced neuroimaging and artificial intelligence/machine learning (AI/ML) technology. His research has been focused on technical development, neuroscience and clinical applications of advanced imaging methods for mapping structure and function of the human brain, especially diffusion MRI, which is a popular technique for assessing the development and integrity of white matter and for mapping axonal fiber pathways.
 Scope:  Dr. Mukherjee will discuss his work on traumatic brain injury with the TRACK-TBI trial and on advanced neuroimaging and artificial intelligence/machine learning (AI/ML) technology.

Open Office Hours – Every Tuesday 9-10 a.m. MDT!

Join us for open office hours! Ask questions about your phantom, qCal-MR and meet others advancing quantitative MRI!

Article Word Cloud!

Take a look at our word cloud: qMRI, imaging, diffusion, T1, T2 ADC Mapping! Reproduciblity! QA/QC! Repeatability, Reproducibility, QA/QC!

CaliberMRI announces release of the qDisc, a new quantitative MRI phantom for added functionality of the Medium ACR Phantom

BOULDER, Colo., Nov. 26, 2025 /PRNewswire/ — CaliberMRI, an industry leader in standardizing Magnetic Resonance Imaging (MRI), announced the release of a new quantitative MRI phantom compatible with the Medium ACR phantom. CaliberMRI’s qDisc (quantitative Dual Imaging Standardization Compartment) Model 141 allows sites to baseline T1, T2, ADC, and Proton Density in a single slice when scanning the Medium ACR phantom. The qDisc includes the Company’s patented MR readable LC Thermometer and is supported by qCal-MR®, an automated QA/QC analysis software. “This offering provides a practical option for gathering important quantitative metrics during routine scans with an ACR phantom,” says William Hollander, CEO of CaliberMRI. “With the rise of quantitative MRI offerings, the qDisc can be used as a first step toward harmonization of MRI scanners and AI software for analysis”. Hollander added. This phantom is intended to complement CaliberMRI’s more complete phantom platform solutions.

Join Us at RSNA – Booth 7610 – North Hall Level 3

Heading to RSNA?  We’ll be exhibiting at Booth 7610 (North Hall Level 3) and would love to discuss QA/QC, AI/ML/DL testing and validation, R&D, and/or custom solutions.  Our cloud-based software, qCal-MR, now supports more than 45 scanner makes and models on Canon, GEHC, Hyperfine, Philips, Siemens, and United Imaging Scanners.  We’ll be showcasing our new products, and are available to discuss collaborations.  Reach out if you’d like to set up a meeting.

Great Reading For ASTRO!

Are you heading to ASTRO next week?  If so, take a look at some incredible articles below (some hot off the press!).  Please reach out directly to authors on their work or to CaliberMRI on our phantoms.  If you’d like to set up a meeting at ASTRO, please reach out to us directly at info@qmri.com. […]

CaliberMRI receives grant for work in Africa and Southeast Asia

Quantitative MRI technology developer CaliberMRI has received a grant from the Bill & Melinda Gates Foundation to help standardize portable MRI imaging for neonatal and pediatric brain development of children in Africa and Southeast Asia.

CaliberMRI, Inc. and RSNA’s QIBA Announce First Conformance Certification for Diffusion-Weighted MRI

If this is your first time uploading a Study, your study will be uploaded without being placed inside a folder.

CaliberMRI, Inc. Announces Award to Improve Pediatric Brain Imaging at More than 25 Sites Around the World

If this is your first time uploading a Study, your study will be uploaded without being placed inside a folder.

CaliberMRI, Inc. Announces Award to Improve Pediatric Brain Imaging at More than 25 Sites Around the World

CaliberMRI, an industry leader in standardization of Magnetic Resonance Imaging (MRI), has been awarded a grant from the Bill & Melinda Gates Foundation to improve repeatability and reproducibility of diagnostic imaging for neonatal and pediatric brain development of children in Africa and Southeast Asia. CaliberMRI supports research into pediatric brain development through standardization and calibration of low […]

CaliberMRI Receives State Grant for Biomimetic Quantitative MRI Development

Boulder, Colorado — CaliberMRI is honored to announce it has been awarded an Early-Stage  Capital and Retention grant through the Colorado Office of Economic Development and International Trade (OEDIT) Advanced Industries Accelerator program. This funding will help further quantitative Magnetic Resonance Imaging (qMRI) through the development of biomimetic phantoms for use in breast cancer treatment and therapy monitoring. […]